Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-2

Pralmorelin, Growth Hormone Releasing Peptide-2, KP-102

Quick Stats
Studies 230
Trials 1
2014 pubmed 35 citations

A high-throughput LC-MS/MS screen for GHRP in equine and human urine, featuring peptide derivatization for improved chromatography.

Timms. Mark M; Hall. Nikki N; Levina. Vita V; Vine. John J; Steel. Rohan R

Key Findings

  • A solid‑phase extraction combined with a new derivatization step improves chromatography of basic peptides like GHRPs.
  • The LC‑MS/MS method can reliably detect all eight studied GHRPs (or their metabolites) in urine.
  • The assay was validated for linearity, precision, specificity, detection limits, ion suppression, and stability.

Practical Outcomes

  • For biohackers, the study mainly signals that sophisticated urine tests exist to catch GHRP use, but it does not provide dosing guidance, safety data, or performance benefits. It’s useful for awareness of detection risk rather than for optimizing personal protocols.

Summary

The paper describes a lab test that can spot a group of synthetic growth‑hormone‑releasing peptides (including GHRP‑2) in horse or human urine. It focuses on how to extract and chemically modify the peptides so they show up better on a mass‑spectrometer, and it proves the test works in rats.

Abstract

The growth hormone releasing peptides (GHRPs) hexarelin, ipamorelin, alexamorelin, GHRP-1, GHRP-2, GHRP-4, GHRP-5, and GHRP-6 are all synthetic met-enkephalin analogues that include unnatural D-amino acids. They were designed specifically for their ability to stimulate growth hormone release and may serve as performance enhancing drugs. To regulate the use of these peptides within the horse racing industry and by human athletes, a method is presented for the extraction, derivatization, and detection of GHRPs from equine and human urine. This method takes advantage of a highly specific solid-phase extraction combined with a novel derivatization method to improve the chromatography of basic peptides. The method was validated with respect to linearity, repeatability, intermediate precision, specificity, limits of detection, limits of confirmation, ion suppression, and stability. As proof of principle, all eight GHRPs or their metabolites could be detected in urine collected from rats after intravenous administration.

Study Information

Provider

pubmed

Year

2014

Date

2014-02-24T00:00:00.000Z

DOI

10.1002/dta.1624

Citations

35

References

22